ARIPIPRAZOLE
| Brand name | ABILIFY |
|---|---|
| Active ingredient | ARIPIPRAZOLE |
| Strength | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2006 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8759350 | March 2027 | use U-1529 |
| 9125939 | July 2026 | use U-1749 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.